| Procter & Gamble Health Ltd. announced its financial results for the first quarter ended June 30, 2026, reporting sales of Rs 356 crores, a 7% increase compared to a year ago, and a Profit After Tax (PAT) of Rs 96 crores, up 45% year-over-year, driven by strong brand fundamentals, strengthened supply chain, and one-time proceeds from the sale of an immovable asset; Operational Profit After Tax (PAT) was Rs 72 crores, up 9% versus a year ago excluding the one-time proceeds, according to a press release. |